Keratoconjunctivitis - 40 Studies Found Completed : A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease : Keratoconjunctivitis Sicca : 2012-11-21 : Drug: R348 Ophthalmic Solution, 0.2% Completed : Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months : Vernal Keratoconjunctivitis Healthy Children : 2013-11-25 : Procedure: Cytokins assay in tears Completed : Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis : Keratoconjunctivitis Conjunctivitis : 2007-12-03 : Drug: FK506 Ophthalmic suspension Other Name: tacrol Completed : A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome : Keratoconjunctivitis Sicca : 2014-05-06 : Drug: Retaine™ Completed : Study of Rebamipide Eye Drops to Treat Dry Eye : Keratoconjunctivitis Sicca : 2005-09-12 : Drug: Rebamipide OPC as a Terminated : Omega-3 Fatty Acid Supplements and Dry Eye : Keratoconjunctivitis Sicca : 2010-09-30 : Dietary Supplement: Omega-3 Fatty Acid Completed : A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye : Keratoconjunctivitis Sicca : 2015-12-16 : Drug: 1% Tavilermide Ophthalmic Solution Completed : Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye : Keratoconjunctivitis Sicca : 2002-05-18 : Drug: INS365 Ophthalmic Solution Completed : A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease : Keratoconjunctivitis Sicca : 2016-01-20 : Drug: 1% Tavilermide Ophthalmic Solution Completed : TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease : Keratoconjunctivitis Sicca : 2009-02-18 <<< Previous | Next >>>
